Month: May 2022

Why change to Cesium -131?

Why would a clinician be hesitant to use Cesium-131 to treat prostate cancer? I would venture to say the likely answer is the data that speaks to its benefits has not yet diffused through the system…

Isoray Announces Record Third Quarter Fiscal 2022 Financial Results

Revenue for the third quarter of fiscal 2022 grew 12% to $2.91 million versus $2.60 million in the prior year comparable period.

Scroll to top